These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 12486438)

  • 21. Cognitive functioning in 8- to 18-month-old drug-exposed infants.
    Alessandri SM; Bendersky M; Lewis M
    Dev Psychol; 1998 May; 34(3):565-73. PubMed ID: 9597365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Thirty-six-month outcome of prenatal cocaine exposure for term or near-term infants: impact of early case management.
    Kilbride H; Castor C; Hoffman E; Fuger KL
    J Dev Behav Pediatr; 2000 Feb; 21(1):19-26. PubMed ID: 10706345
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heart rate variability alterations in infants with spontaneous hypertonia.
    Arce-Alvarez A; Melipillán C; Andrade DC; Toledo C; Marcus NJ; Del Rio R
    Pediatr Res; 2019 Jul; 86(1):77-84. PubMed ID: 30755711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The dynamics of cardiac autonomic control in sleeping preterm neonates exposed in utero to smoking.
    Stéphan-Blanchard E; Chardon K; Djeddi DD; Léké A; Delanaud S; Bach V; Telliez F
    Clin Neurophysiol; 2016 Aug; 127(8):2871-2877. PubMed ID: 27246968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Longitudinal influence of prenatal cocaine exposure on child language functioning.
    Bandstra ES; Morrow CE; Vogel AL; Fifer RC; Ofir AY; Dausa AT; Xue L; Anthony JC
    Neurotoxicol Teratol; 2002; 24(3):297-308. PubMed ID: 12009485
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intrauterine growth of full-term infants: impact of prenatal cocaine exposure.
    Bandstra ES; Morrow CE; Anthony JC; Churchill SS; Chitwood DC; Steele BW; Ofir AY; Xue L
    Pediatrics; 2001 Dec; 108(6):1309-19. PubMed ID: 11731653
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Level of in utero cocaine exposure and neonatal ultrasound findings.
    Frank DA; McCarten KM; Robson CD; Mirochnick M; Cabral H; Park H; Zuckerman B
    Pediatrics; 1999 Nov; 104(5 Pt 1):1101-5. PubMed ID: 10545554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neuromotor development of cocaine-exposed and control infants from birth through 15 months: poor and poorer performance.
    Fetters L; Tronick EZ
    Pediatrics; 1996 Nov; 98(5):938-43. PubMed ID: 8909489
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diastolic filling abnormalities by color kinesis in newborns exposed to intrauterine cocaine.
    Mehta SK; Super DM; Salvator A; Singer L; Connuck D; Fradley LG; Harcar-Sevcik RA; Thomas JD; Sun JP
    J Am Soc Echocardiogr; 2002 May; 15(5):447-53. PubMed ID: 12019428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of in utero substance exposure on infant neurobehavior.
    Napiorkowski B; Lester BM; Freier MC; Brunner S; Dietz L; Nadra A; Oh W
    Pediatrics; 1996 Jul; 98(1):71-5. PubMed ID: 8668415
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Maternal Lifestyle Study (MLS): effects of prenatal cocaine and/or opiate exposure on auditory brain response at one month.
    Lester BM; Lagasse L; Seifer R; Tronick EZ; Bauer CR; Shankaran S; Bada HS; Wright LL; Smeriglio VL; Liu J; Finnegan LP; Maza PL
    J Pediatr; 2003 Mar; 142(3):279-85. PubMed ID: 12640376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal cocaine and neuromotor outcome at four months: effect of duration of exposure.
    Swanson MW; Streissguth AP; Sampson PD; Olson HC
    J Dev Behav Pediatr; 1999 Oct; 20(5):325-34. PubMed ID: 10533991
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The search for congenital malformations in newborns with fetal cocaine exposure.
    Behnke M; Eyler FD; Garvan CW; Wobie K
    Pediatrics; 2001 May; 107(5):E74. PubMed ID: 11331724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Late dose-response effects of prenatal cocaine exposure on newborn neurobehavioral performance.
    Tronick EZ; Frank DA; Cabral H; Mirochnick M; Zuckerman B
    Pediatrics; 1996 Jul; 98(1):76-83. PubMed ID: 8668416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pain reactivity in 2-month-old infants after prenatal and postnatal serotonin reuptake inhibitor medication exposure.
    Oberlander TF; Grunau RE; Fitzgerald C; Papsdorf M; Rurak D; Riggs W
    Pediatrics; 2005 Feb; 115(2):411-25. PubMed ID: 15687451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prenatal Exposure to
    Cowell WJ; Brunst KJ; Malin AJ; Coull BA; Gennings C; Kloog I; Lipton L; Wright RO; Enlow MB; Wright RJ
    Environ Health Perspect; 2019 Oct; 127(10):107007. PubMed ID: 31663780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of sudden infant death syndrome among infants with in utero exposure to cocaine.
    Bauchner H; Zuckerman B; McClain M; Frank D; Fried LE; Kayne H
    J Pediatr; 1988 Nov; 113(5):831-4. PubMed ID: 3183836
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neurobehavioral outcomes of cocaine-exposed infants.
    Singer LT; Arendt R; Minnes S; Farkas K; Salvator A
    Neurotoxicol Teratol; 2000; 22(5):653-66. PubMed ID: 11106858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrauterine cocaine exposure and the risk for sudden infant death syndrome: a meta-analysis.
    Fares I; McCulloch KM; Raju TN
    J Perinatol; 1997; 17(3):179-82. PubMed ID: 9210070
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cocaine exposure and developmental outcome from birth to 6 months.
    Behnke M; Eyler FD; Garvan CW; Wobie K; Hou W
    Neurotoxicol Teratol; 2002; 24(3):283-95. PubMed ID: 12009484
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.